Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal

Clinical trial NCT00723177 · COMPLETED

Trial details

NCT number: NCT00723177
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-Related Disorders

Start date: 2008-10-01
Primary completion: 2010-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.